MONASH IVF GROUP LIMITED (MVF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

MVF - MONASH IVF GROUP LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.10

20 May
2022

0.010

OPEN

$1.06

0.92%

HIGH

$1.12

947,063

LOW

$1.06

TARGET
$1.237 12.4% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . SLA . CAJ . GXL . HSO . MPL . NHF . HLS . RHC . SHL . VRT . MDR . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . BMT . NVL . AHX . ALC . ACL .
FNARENA'S MARKET CONSENSUS FORECASTS
MVF: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx 6.5 6.0 xxx
DPS (cps) xxx 4.2 4.2 xxx
EPS Growth xxx 41.8% - 6.5% xxx
DPS Growth xxx 100.0% 0.0% xxx
PE Ratio xxx N/A 18.2 xxx
Dividend Yield xxx N/A 3.8% xxx
Div Pay Ratio(%) xxx 65.1% 69.6% xxx

Dividend yield today if purchased 3 years ago: 3.72%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.82

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 07/03 - ex-div 2.2c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx6.5
DPS All xxxxxxxxxxxxxxx4.2
Sales/Revenue xxxxxxxxxxxxxxx183.6 M
Book Value Per Share xxxxxxxxxxxxxxx68.4
Net Operating Cash Flow xxxxxxxxxxxxxxx43.3 M
Net Profit Margin xxxxxxxxxxxxxxx13.70 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Capital Employed xxxxxxxxxxxxxxx9.74 %
Return on Invested Capital xxxxxxxxxxxxxxx8.24 %
Return on Assets xxxxxxxxxxxxxxx7.07 %
Return on Equity xxxxxxxxxxxxxxx9.74 %
Return on Total Capital xxxxxxxxxxxxxxx11.16 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx20.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

19/05/2022

1

Outperform

$1.20

9.09%

Monash IVF has acquired PIVET adding nine fertility specialists to the company's stable.

Macquarie estimates the deal was struck on a 5x multiple (excluding earn-outs) and is 3% accretive to EPS.

The broker views the deal as a plus, underpinning cycle growth, and believes the company is well placed for growth and market-share gains.

Outperform rating and $1.20 target price retained.

FORECAST
Macquarie forecasts a full year FY22 dividend of 3.60 cents and EPS of 5.80 cents.
Macquarie forecasts a full year FY23 dividend of 4.50 cents and EPS of 6.50 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

MVF STOCK CHART